In Japan, Expanding a Label Is What Triggers the Price Cut
Dupixent, Nucala and Vyvdura were all cut after adding an indication. In Japan the trigger for a price cut is the drug reaching more patients.
DealPulse Signal
The Beats
Analysis
The Briefs
In Japan, Expanding a Label Is What Triggers the Price Cut
Black Diamond Bought a Licence Instead of a Ruling, and Six Patents Stay Untested
Australia Cannot Settle Its Device Price Fight While the Service Sits Inside the Price
Oman Is Offering Drug Manufacturers the One Thing Government Procurement Normally Destroys
Freenome’s Lung Test Is Indicated for People Who Never Show Up